Skip to content

SDSPHAR: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

SDSPHAR

BE 0721.936.158
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€203,366
2024 · €130,076+€73,291
Equity
€21,745
2024 · €28,378-€6,634
Cash
€174,359
2024 · €99,282+€75,077
Balance sheet total
€740,622
2024 · €726,240+€14,382

Largest movements

2024 to 2025
Assets
  • Cash +€75,077

    up €75,077 (+75.6%), from €99,282 to €174,359

    mainly Net result for the year (+€203,366) and Other debts (+€64,416)

  • Receivables within one year -€52,839

    down €52,839 (-29.7%), from €177,840 to €125,001

    of which Trade receivables: -€43,686

  • Stocks and contracts +€23,892

    up €23,892 (+17.4%), from €137,653 to €161,545

  • Intangible fixed assets -€20,000

    down €20,000 (-22.9%), from €87,507 to €67,507

  • Tangible fixed assets -€13,247

    down €13,247 (-6.2%), from €213,463 to €200,216

    of which Plant, machinery and equipment: -€11,963

Equity and liabilities
  • Other debts +€64,416

    up €64,416 (+31.5%), from €204,213 to €268,629

  • Trade debts -€50,345

    down €50,345 (-27.0%), from €186,269 to €135,923

Income statement
  • Gross operating margin +€132,421

    up €132,421 (+48.9%), from €270,543 to €402,964

  • Taxes +€29,803

    up €29,803 (+66.5%), from €44,847 to €74,650

  • Depreciation +€13,517

    up €13,517 (+40.1%), from €33,727 to €47,244

  • Staff costs +€10,451

    up €10,451 (+19.6%), from €53,391 to €63,843

  • Financial charges +€5,254

    up €5,254 (+60.1%), from €8,748 to €14,002

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €130,076
Gross operating margin +€132,421
Staff costs -€10,451
Depreciation -€13,517
Other operating charges +€2
Financial income -€107
Financial charges -€5,254
Taxes -€29,803
Result 2025 €203,366

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€291,677
Investment -€13,997
Financing -€202,603
Cash 2024 €99,282
Net result for the year +€203,366
Depreciation +€47,244
Stocks and contracts -€23,892
Receivables within one year +€52,839
Deferred charges and accrued income -€1,499
Trade debts -€50,345
Tax, wage and social debts -€452
Other debts +€64,416
Investment in fixed assets (net) -€17,313
Current investments +€3,316
Debts after one year +€4,043
Current portion of long-term debt +€3,354
Contributions, distributions and other -€210,000
Cash 2025 €174,359
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €726,240 €740,622 +€14,382 +2.0%
Fixed assets 21/28 €306,968 €277,037 -€29,931 -9.8%
Intangible fixed assets 21 €87,507 €67,507 -€20,000 -22.9%
Tangible fixed assets 22/27 €213,463 €200,216 -€13,247 -6.2%
Plant, machinery and equipment 23 €211,052 €199,089 -€11,963 -5.7%
Furniture and vehicles 24 €2,411 €1,127 -€1,284 -53.3%
Financial fixed assets 28 €5,998 €9,314 +€3,316 +55.3%
Current assets 29/58 €419,273 €463,586 +€44,313 +10.6%
Stocks and contracts in progress 3 €137,653 €161,545 +€23,892 +17.4%
Stocks 30/36 €137,653 €161,545 +€23,892 +17.4%
Amounts receivable within one year 40/41 €177,840 €125,001 -€52,839 -29.7%
Trade receivables 40 €168,687 €125,001 -€43,686 -25.9%
Other amounts receivable 41 €9,153 - -€9,153
Current investments 50/53 €3,316 - -€3,316
Cash at bank and in hand 54/58 €99,282 €174,359 +€75,077 +75.6%
Deferred charges and accrued income 490/1 €1,181 €2,681 +€1,499 +126.9%
Total equity and liabilities 10/49 €726,240 €740,622 +€14,382 +2.0%
Equity 10/15 €28,378 €21,745 -€6,634 -23.4%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €1,580 €1,580 = 0.0%
Non-distributable reserves 130/1 €1,580 €1,580 = 0.0%
Reserves not available under the articles 1311 €1,580 €1,580 = 0.0%
Profit (loss) carried forward 14 €8,198 €1,565 -€6,634 -80.9%
Amounts payable 17/49 €697,862 €718,878 +€21,015 +3.0%
Amounts payable after more than one year 17 €213,404 €217,447 +€4,043 +1.9%
Financial debts 170/4 €213,404 €217,447 +€4,043 +1.9%
Amounts payable within one year 42/48 €484,458 €501,431 +€16,972 +3.5%
Current portion of amounts payable after more than one year 42 €50,825 €54,178 +€3,354 +6.6%
Trade debts 44 €186,269 €135,923 -€50,345 -27.0%
Suppliers 440/4 €186,269 €135,923 -€50,345 -27.0%
Taxes, remuneration and social security 45 €43,153 €42,700 -€452 -1.0%
Taxes 450/3 €31,332 €32,656 +€1,324 +4.2%
Remuneration and social security 454/9 €11,821 €10,044 -€1,777 -15.0%
Other amounts payable 47/48 €204,213 €268,629 +€64,416 +31.5%
Remuneration, social security and pensions 62 €53,391 €63,843 +€10,451 +19.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €33,727 €47,244 +€13,517 +40.1%
Other operating charges 640/8 €2 - -€2
Gross operating margin 9900 €270,543 €402,964 +€132,421 +48.9%
Operating profit (loss) 9901 €183,423 €291,877 +€108,454 +59.1%
Financial income 75/76B €248 €141 -€107 -43.1%
Recurring financial income 75 €248 €141 -€107 -43.1%
Financial charges 65/66B €8,748 €14,002 +€5,254 +60.1%
Recurring financial charges 65 €8,748 €14,002 +€5,254 +60.1%
Profit (loss) for the period before taxes 9903 €174,923 €278,016 +€103,093 +58.9%
Income taxes 67/77 €44,847 €74,650 +€29,803 +66.5%
Profit (loss) for the period 9904 €130,076 €203,366 +€73,291 +56.3%
Profit (loss) for the period to be appropriated 9905 €130,076 €203,366 +€73,291 +56.3%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.